Summary
- Current Price
- As of today, MRNA price is $137.99, down -3.35% on
- Current Price All-Time High
- MRNA price is currently -72.26% below its historical high of $497.49 set on
- Market Cap
- MRNA current market cap is $55B, up +478.75% over the past 365 days
- Revenue
- MRNA current annual revenue is $1.94B, down -39.93% year-over-year
- Next Earnings
- The next earnings release for MRNA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Moderna, Inc. |
| Ticker | NASDAQ: MRNA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | |
| Website | modernatx.com |
| Employees | 5,800 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $137.99 | |
| Price, 1D Change | -3.35% | |
| Market Cap | $55B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.90 | |
| Revenue | $1.94B | |
| Revenue, 1Y Change | -39.93% | |
| EPS | -$7.25 | |
| EPS, 1Y Change | +21.77% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$7.25 | |
| EPS Estimate | -$8.55 | N/A |
| EPS Est. Change | -17.89% | N/A |
| Revenue | $1.94B | |
| Revenue Estimate | $2.11B | N/A |
| Revenue Est. Change | +8.35% | N/A |
| Current Price | $137.99 | |
| Price Target | $120.00 | - |
| Price Tgt. Change | -13.04% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$9.15 | -$9.27 | -1.30% | |
| -$7.89 | -$7.25 | +8.04% | |
| -$8.55 | N/A | -17.89% | |
| -$4.90 | N/A | +32.50% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.22B | $3.24B | +0.58% | |
| $1.88B | $1.94B | +3.55% | |
| $2.11B | N/A | +8.35% | |
| $2.47B | N/A | +27.26% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +463.91% | |
| Price, 3Y | +21.22% | |
| Market Cap, 1Y | +478.75% | |
| Market Cap, 3Y | +27.03% | |
| Revenue, 1Y | -39.93% | |
| Revenue, 3Y | -89.83% | |
| EPS, 1Y | +21.77% | |
| EPS, 3Y | -136.09% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $137.99 | |
| SMA 200 | $51.76 | |
| SMA 50 | $76.79 | |
| EMA 200 | $57.66 | |
| EMA 50 | $83.55 | |
| MACD | $23.44 | |
| Beta | 1.90 | |
| ATR | $14.64 | |
| 14-Day RSI | 63.54 | |
| 10-Day Volatility | 912.71% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $1.94B | |
| EPS | -$7.25 | |
| Gross Profit | $0.00 | |
| Gross Margin | 55.35% | |
| Operating Income | -$3.07B | |
| Operating Margin | -158.13% | |
| Net Income | -$2.82B | |
| Net Margin | -145.16% | |
| EBITDA | -$2.86B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.15 | |
| 3.29 | ||
| 3.22 | ||
| - | ||
| 2 | ||
| 10.38 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| 24.73 | ||
| 8.15 | ||
| -16.64 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $8.65B | |
| $5.80B | ||
| $12.34B | ||
| $6.54B | ||
| $3.69B | ||
| $1.99B | ||
| Total Debt | $1.31B | |
| $42.00M | ||
| $317.00M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $4.77B | ||
| $4.15B | ||
| $868.00M | ||
| $0.00 | ||
| $215.00M | ||
| $0.00 | ||
| $54.00M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$1.85B | ||
| $1.95B | ||
| $572.00M | ||
| Capex | $202.00M | |
| -$2.05B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wolfe Research | → | |
| Barclays | → | |
| JP Morgan | → | |
| UBS | → | |
| Morgan Stanley | → | |
| Goldman Sachs | → | |
| William Blair | → | |
| Citigroup | → | |
| Goldman Sachs | → | |
| Morgan Stanley | → |
Analyst sentiment
Institutional ownership
Screeners with MRNA
FAQ
- What is the ticker symbol for Moderna, Inc.?
- The ticker symbol for Moderna, Inc. is NASDAQ:MRNA
- Does Moderna, Inc. pay dividends?
- No, Moderna, Inc. does not pay dividends
- What sector is Moderna, Inc. in?
- Moderna, Inc. is in the Healthcare sector
- What industry is Moderna, Inc. in?
- Moderna, Inc. is in the Biotechnology industry
- What country is Moderna, Inc. based in?
- Moderna, Inc. is headquartered in United States
- When did Moderna, Inc. go public?
- Moderna, Inc. initial public offering (IPO) was on December 7, 2018
- Is Moderna, Inc. in the S&P 500?
- Yes, Moderna, Inc. is included in the S&P 500 index
- Is Moderna, Inc. in the NASDAQ 100?
- No, Moderna, Inc. is not included in the NASDAQ 100 index
- Is Moderna, Inc. in the Dow Jones?
- No, Moderna, Inc. is not included in the Dow Jones index
- When was Moderna, Inc. last earnings report?
- Moderna, Inc.'s most recent earnings report was on July 31, 2026
- When does Moderna, Inc. report earnings?
- The next expected earnings date for Moderna, Inc. is November 5, 2026
Data Sources & References
- MRNA Official Website www.modernatx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1682852/000162828025053816/0001628280-25-053816-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- MRNA Profile on Yahoo Finance finance.yahoo.com/quote/MRNA
- MRNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrna